Andrx Corp. and Watson Pharmaceuticals have signed a definitive merger agreement providing for the acquisition of Andrx by Watson. Dates for closing the acquisition have not yet been determined.
Andrx and Watson reach agreement to merge
Andrx Corp. and Watson Pharmaceuticals have signed a definitive merger agreement providing for the acquisition of Andrx by Watson. Dates for closing the acquisition have not yet been determined.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.